Tuesday, February 22, 2022

APOLLOHOSP

APOLLOHOSP

24.11.2022 - CS on Apollohosp Maintain Outperform CMP 4815 Target 5100
14.11.2022 - MS on Apollohosp Maintain Overweight CMP 4546.35 Target 5332
16.08.2022 - GS on Apollohosp Maintain Buy CMP 4343.05 Target 4900
16.08.2022 - MS on Apollohosp Maintain Overweight CMP 4343.05 Target 5332
16.08.2022 - CS on Apollohosp Maintain Outperform CMP 4343.05 Target 4960
16.08.2022 - HSBC on Apollohosp Maintain Buy CMP 4343.05 Target 5020
12.07.2022 - CLSA on Apollohosp Maintain Outperform CMP 3913 Target 4470
06.07.2022 - CS on Apollohosp Maintain Outperform CMP 3887.95 Target 4350
14.02.2022 - GS on Apollohosp Maintain Buy CMP 4515 Target 4970
14.02.2022 - Kotak Instel EQ on Apollohosp Maintain Add CMP 4515 Target 5257
14.02.2022 - CLSA on Apollohosp Maintain Buy CMP 4515 Target 5250
14.02.2022 - CITI on Apollohosp Maintain Buy CMP 4515 Target 5800
20.01.2022 - Jefferies on Apollohosp Maintain Buy CMP 4516 Target 6060
18.01.2022 - CS on Apollohosp Maintain Outperform CMP 4617 Target 5800

UBS ON APOLLO HOSPITAL : 28.06.2021

• Maintain BUY, Target at Rs 3,850/share
* Apollo setting runway for digital flight
* Getting in position to create potentially digital healthcare platform
* Steady growth/profitability outlook
• Continued strong performance during Q4

MACQUARIE ON APOLLO HOSPITAL : 24.06.2021

* Sharper omni-channel focus post restructuring
* Existing hospitals EBITDA margin touches high of 23%
• Apollo has diversified presence, improved execution
* Companies focused on cost holds it in good stead
• Slower than expected normalisation in footfall is a risk

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830